Protalix Biotherapeutics, Inc. (PLX)

2.035 -0.02 (-0.73%) USD  |  NYAM  |  Jan 21, 10:43
More

Protalix Biotherapeutics Preferred Stock (Quarterly)

Preferred Stock (Quarterly) Chart

View Preferred Stock (Quarterly) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (Quarterly) Range, Past 5 Years

View Preferred Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (Quarterly) Benchmarks

View Preferred Stock (Quarterly) Benchmarks
Start Trial
OraSure Technologies, Inc. Upgrade
PAVmed, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade